Boys Arnold & Co’s Elevance Health ELV Stock Holding History

Boys Arnold & Co’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-666	Closed	-$201K	–	253
2019 Q4	$201K	Buy	+666	New	+$183K	0.03%	265

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boys Arnold & Co's ELV Position: Q1 2020 in Review

Boys Arnold & Co sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 666 shares — an estimated $201K sold.

Boys Arnold & Co first reported a position in ELV in Q4 2019 and held it in 1 quarter. The position peaked at $201K in Q4 2019. 1,053 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

Boys Arnold & Co reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
Boys Arnold & Co sold 666 Elevance Health shares in Q1 2020, an estimated $201K.
Boys Arnold & Co first reported a position in Elevance Health in Q4 2019 and held it in 1 quarter.
Boys Arnold & Co's Elevance Health position peaked at $201K in Q4 2019.
1,053 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Boys Arnold & Co's 13F filing for Q1 2020, filed 24 Apr 2020.